COYA - Company ID 0001835022
The table below shows Coya Therapeutics, Inc.'s balance sheet line items across its last 4 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash & equivalents | $46.82M | $38.34M | $32.63M | $5.93M |
| Short-term investments | - | - | - | - |
| Receivables | - | - | - | - |
| Inventory | - | - | - | - |
| Total current assets | $49.94M | $44.31M | $41.20M | $7.18M |
| Property, plant & equipment | $11.23K | $38.59K | $65.95K | $93.31K |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Goodwill | - | - | - | - |
| Total assets | $49.95M | $44.35M | $41.26M | $8.40M |
| Accounts payable | $1.06M | $1.59M | $1.16M | $1.82M |
| Total current liabilities | $5.87M | $3.82M | $5.05M | $3.82M |
| Long-term debt | - | - | - | - |
| Total liabilities | $6.92M | $4.77M | $5.63M | $16.79M |
| Retained earnings | -$61.96M | -$40.74M | -$25.86M | -$17.87M |
| Total equity | $43.03M | $39.58M | $35.64M | -$8.39M |